New startup ideas · Health and bio · Healthcare and bio
startup idea
Medrails
The clinical fulfillment API: labs, prescriptions, and licensed review for every health app.
A self-serve API that lets small digital-health companies order real-world clinical actions in code: blood draws routed to a Medrails-operated phlebotomy and lab network, prescriptions reviewed by licensed clinicians, results returned as structured data.
- Infrastructure and APIs
- Small business
- $10-100B market
- Platform others build on
- Global from day one
4/5
venture judge
4
similar startups, last 2 years (13 all-time)
96%
of 3 nearest real companies still alive
yes
8 matching federal grants and programs
Direction supported by government programs and grants
Scorecard
One score that balances how trendy the idea is, the demand for it and its potential for 100x, with competition measured relative to every other idea in the catalog. Recent startup trends first, government priorities second.
91
Idea Score, 0-100 · raw 55.6 x 1.64
Active
competition: more crowded than 47% of ideas · headwind x0.76
+3.2
government priorities, secondary (23 matching grants)
Trend
78
Is the wave forming now? 2025-26 entrants vs 2023-24, rounds since 2025, the sector's live-batch direction, the 2026 trend analyst.
- Entrants 2025-26 vs 2023-24 (similar companies)70
- Rounds announced 2025+ in the sector68
- Sector direction (live batch)100
- 2026 trend analyst75
Demand
60
Does anyone want it? YC's current RFS, companies already paid for something similar, the operator judge, founders' yes-rate in decks, readers who would run the test.
- YC asks for it (current RFS: idea / sector)30
- Someone already pays (similar companies, recent / all-time)100
- Operator judge: real pain50
100x potential
69
Can it return a fund? The venture judge (double weight), market-size and moat axes, neighbours still alive, the technologist judge.
- Venture judge75
- Market size axis67
- Moat axis80
- Neighbours still alive65
- Technologist judge50
Score = 100 x cbrt(Trend x Demand x 100x) x (1 - 0.5 x crowding) + government bonus (max 5), calibrated so the 95th-percentile idea scores 90 (order never changes). A geometric mean: a weak pillar cannot be papered over. Percentiles are among the 272 ideas in the catalog; the terms matched were clinical, fulfillment, labs, prescriptions, licensed, review, self-serve, digital-health.
The idea in full
- What
- A self-serve API that lets small digital-health companies order real-world clinical actions in code: blood draws routed to a Medrails-operated phlebotomy and lab network, prescriptions reviewed by licensed clinicians, results returned as structured data. The buyer is the SMB health startup that cannot afford to build CLIA labs, pharmacy licensure, and clinician networks itself; Medrails carries that regulated, capital-heavy stack once and meters it per transaction with a platform subscription on top.
- Why now
- This cluster added 267 companies in the last two years, including 199 in the 2024 cohort alone, and the newest wave - Clara's AI primary care doctor and Standard Medical's autonomous clinic in YC S26/X26 - all hit the same wall: an AI can decide, but only a licensed, physical network can draw blood and dispense.
- Wedge: first customer and entry point
- Offer a single endpoint, order a metabolic panel with clinician review, in three US states plus the UK, and onboard 20 seed-stage AI-health startups from the current accelerator cohorts self-serve.
- Path to 100x
- Lab diagnostics and prescription fulfillment are a market in the tens of billions, and infrastructure APIs in such markets follow a power law: whichever rails the current cohort of hundreds of AI-health startups embeds becomes the default for the next thousand, because switching regulated fulfillment providers means re-verifying licensure in every state and country. That embedded distribution moat lets the winner take a percentage of an entire generation of care delivery, the way payment APIs did for commerce.
- Ceiling
- If the few AI-care companies that reach scale vertically integrate their own labs and clinician networks, Medrails keeps only the long tail and plateaus as mid-size infrastructure.
- Closest real companies, as the generator saw them
- Hubble retrieves records other APIs cannot, which is read-only data access; Medrails is write access to the clinical world, executing orders and fulfillment. Clara and Standard Medical are AI care providers who would build on these rails rather than compete with them.
- Main risk
- The physical lab and clinician network burns capital linearly across every new geography while API customers stay small and churn with startup mortality.
Five judges
Each judge scores every idea in the catalog with a named rubric; the venture judge decides whether a card is shown at all (4-5 is venture-grade).
Venture investor
4/5
Whichever rails the 199-company cohort embeds becomes default for the next thousand, and re-verifying licensure per state makes switching brutal.
Bootstrapper
2/5
Operating CLIA labs and pharmacy licensure per state is heavy capital, and seed-stage startup customers churn with startup mortality.
Operator
3/5
Real painkiller for AI-health startups that already pay for labs and clinician review, but the buyer is seed-stage and churns with startup mortality.
Technologist
3/5
Phlebotomy networks and multi-state licensure are hard to assemble but the moat is regulatory and operational, and it burns capital linearly per geography.
Risk
3/5
Holding CLIA and pharmacy licensure itself is solid footing, undercut by a customer base of 20 seed-stage startups with high mortality and churn.
trends
4/5
Only sellable now because the 2025-2026 wave of AI clinics like Clara and Standard Medical needs physical fulfillment rails it cannot build.
Similar startups in the directory
Companies whose pitch matches most of the idea's terms (clinical, fulfillment, labs, prescriptions, licensed, review, self-serve, digital-health): 13 all-time, 4 from the last two years. Same matching as Idea Check.
A primary care clinic where AI earns clinical autonomy
Avion builds and operates autonomous eVTOL drones that deliver vital…
AI primary care doctor
An AI primary care doctor in your pocket
Personal doctors through chat
Open-Source Platform for Healthcare Data Intelligence
Democratizing access to precision weight loss medications
Operator of a software and logistics remote diagnostics company intended to offer at-home self-collected diagnostic testing services. The company integrates with clients so that they can offer at-home testing kits on behalf of patients to collect samples at home and send them back to partner labs, that are reviewed by licensed clinicians, thereby enabling customers to access remote diagnostics with secure infrastructure or preferred tech stack.
India's fastest medicine delivery in just 30 minutes
Modern & comprehensive health insurance plan for employees in India
An online provider for greater mental health
Diagnostikare provides a virtual-first primary care service with a focus on preventive health through a data-driven model.
The generator's reference companies
Real companies the model named as closest when it wrote the card, with their fate. A check mark is a company the radar could verify in its directory.
Public money in this direction
US federal grants, SBIR/STTR awards and open opportunities from the radar's public-money feed, matched to the idea's terms; the sector totals give the context.
8
grants and programs matching the idea
1127
startup-relevant grants in Healthcare and bio
$590M
awarded in the sector, tracked
130
opportunities open now in the sector
- I-Corps: Translation Potential of an Autonomous Brain-on-a-Chip Platform for Functional Drug Discoveryawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-14
NIH / NHLBI · SBIR phase II · $1M · posted 2026-08-10
- I-Corps: Translation Potential of a Digital Pet Health Management Software Platformawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-10
- SBIR Phase II: Ai-mediated Neurotechnology for Enhanced Access to Virtual and Physical Realityawardhigh relevance
National Science Foundation · SBIR Phase II · $1M · posted 2026-08-04
- I-Corps: Translation potential of a cell culture technology that synchronizes cellular circadian rhythms through precise temperature oscillationsawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-07-24
- SBIR Phase II: AI-Driven Visualization of Rehabilitation Documentation to Support Decision-Making Across Care Settingsawardhigh relevance
National Science Foundation · SBIR Phase II · $1M · posted 2026-07-20
- Developing a Learning Platform to Support Minimally Verbal Individuals with Autismawardhigh relevance
NIH / NIDCD · STTR phase I · $313K · posted 2026-07-01
- Industrial production of milk extracellular vesicles for dual-use as a systemic radiotherapeutic medical countermeasure and cancer adjuvant therapyawardhigh relevance
NIH / NCATS · SBIR phase II · $986K · posted 2026-07-01
Market signal
What the radar sees in Healthcare and bio: new companies by cohort year, the forming YC batch, and outcomes since the February snapshot.
Healthcare and bio · 130 → 118 → 216 → 173 → 71 new companies 2022 → 2026 · 92% aliveYC S26: 14 in this cluster, 6% of the batch (was 4% in X26) (F26 is still forming: 21 listed)Since February, of 444 YC companies here: 4 acquired, 5 shut down, 37 rewrote their pitch
Design attributes
The card is one cell of a designed set: every axis below was chosen before the text was written, and the text had to realize it.
- Buyer
- Small business
- Business model
- Infrastructure and APIs
- Path to 100x
- Platform others build on
- Market size
- $10-100B market
- Capital intensity
- Capital-heavy (hardware, bio, infra)
- Speed to revenue
- Revenue in 1-3 years
- Technical depth
- Real engineering
- Go-to-market
- Self-serve
- Moat
- Distribution moat
- Geography
- Global from day one
- Regulation
- Heavily regulated
- Vibe
- Hot space
Listed under
An idea sits in its own sector and in any sector its text clearly touches.
More ideas like this
Health and bio · Healthcare and bio
Bylaw Health
The licensed medical group behind your API call, in fifty states.
Bylaw Health holds the professional corporations, state clinician licenses, supervision agreements and payer enrollments in every US state, and exposes them as endpoints: create a clinician, attach a supervising physician, enroll a location with a payer, submit an encounter under a compliant entity.
Health and bio · Healthcare and bio
Bayworks
Licensed GMP manufacturing bays for personalized therapies, sold as bookable capacity.
Bayworks builds standardized, FDA-registered cleanroom modules inside hospital systems and partner CDMO sites, then runs a marketplace where drug sponsors book manufacturing slots by the batch instead of signing multi-year suite reservations.
Health and bio · Healthcare and bio
Assaygrid
Predicts which lab runs will fail before reagents are consumed, across every instrument vendor.
Assaygrid connects to the instrument fleet of pharma, biotech and industrial R&D organizations, learns from run telemetry, reagent lots, operator steps and outcomes, and flags runs likely to fail plus the parameter change that fixes them.
Health and bio · Healthcare and bio
Overturn
Agents that fight payer denials for health systems, then sell what wins.
Overturn deploys an agent workforce inside a health system's revenue cycle that reads each denial, pulls the governing payer medical policy, assembles the clinical record and files the appeal, working through existing EHR and clearinghouse integrations rather than new infrastructure.
Health and bio · Healthcare and bio
Labmesh
Agents that design, order and run preclinical experiments across a global lab network.
Labmesh gives a biotech or pharma scientist an agent that takes a hypothesis, decomposes it into assays, prices and routes each assay to a contract lab on its network, tracks samples, and returns structured results with the raw instrument files.
Health and bio · Healthcare and bio
ChartRail
The consented medical-records rail every AI clinic runs on.
An API that lets AI-native care companies pull a patient's complete medical record with verifiable consent, by operating as a qualified participant in the national health information exchange framework and as a registered clearinghouse.
Fictional company written 2026-08-26 from MarkosWeb data; the companies, grants and numbers around it are real and tracked. Treat the idea as a research prompt, not a plan.